Atopic Dermatitis Drugs Market - Global Forecast 2026-2032

The atopic dermatitis drugs market is evolving rapidly, marked by dynamic innovation and shifting regulatory environments. Senior leaders now face mounting pressure to balance the pursuit of new therapeutic opportunities with the complexities of operational efficiency and patient access.

Market Snapshot: Atopic Dermatitis Drugs Market

The atopic dermatitis drugs market is projected to grow from USD 9.18 billion in 2025 to USD 9.84 billion in 2026 and is anticipated to reach USD 15.78 billion by 2032, reflecting a CAGR of 8.04%. Market expansion is driven by advancements in biologic and small molecule therapies, while ongoing supply and pricing pressures shape strategy across established and emerging regions. Digital transformation continues to inform competitive positioning, with real-world data strengthening compliance and investment frameworks in the global atopic dermatitis drugs market.

Scope & Segmentation

Therapeutic Classes: Covers topical agents (corticosteroids, calcineurin inhibitors, PDE4 inhibitors, vitamin D analogues), biologics, and systemic drugs, each serving specific clinical applications and patient groups.
Administration Formats: Includes creams, gels, lotions, ointments, injectables (with prefilled options), and oral formulations, accommodating preferences and supporting delivery innovation.
Delivery Modes: Encompasses injectable, oral, and topical solutions, allowing customization for patient adherence and varying healthcare environments.
Distribution Networks: Comprises hospital pharmacies, retail pharmacies, digital health channels, direct-to-patient, and subscription models, extending reach and driving access in diverse markets.
Patient Age Cohorts: Pediatric, adult, and geriatric segments guide research initiatives for tailored dosing and safety profiles relevant for each group.
Regions Covered: Report analysis addresses the Americas (including both the United States and Latin America), Europe, Middle East & Africa, and Asia-Pacific, considering region-based regulatory and market nuances.
Emerging Technologies: Digital health, teledermatology, advanced formulation science, and remote monitoring are being leveraged to improve adherence, patient outcomes, and lifecycle management across care settings.

Key Takeaways: Evolving Landscape in Atopic Dermatitis Drugs

The trend toward precision medicine, focusing on targeted and cytokine-specific drugs, is reshaping product offerings and redefining competitive portfolios.
Payers increasingly require evidence-based proof of improved outcomes, while patients look for convenient and effective treatment options, which drives the need for robust value demonstrations.
Strengthening supply chain resilience is a primary consideration, with manufacturers investing in diverse sourcing, contingency planning, and nearshoring to mitigate potential disruptions.
Digital transformation in patient engagement, combined with multi-channel sales and support initiatives, is enhancing flexibility and access in complex regional markets.
Long-term success will hinge on the integration of real-world evidence with advanced delivery systems, alongside reimbursement strategies that support both innovation and sustainable healthcare solutions.

Tariff Impact on Supply Chains and Pricing

Recent tariffs, introduced in 2025, have intensified supply chain difficulties for atopic dermatitis therapies, particularly those entering the United States market. Increased duties affect both finished products and essential active ingredients, elevating logistical costs and administrative demands due to more stringent customs protocols. Injectable biologics—highly dependent on secure and controlled logistics—are especially exposed to these changes. Companies are responding by broadening supplier bases, reinforcing multi-source agreements, and investing in nearshoring strategies to safeguard critical input supply and maintain timely market access.

Methodology & Data Sources

This analysis utilizes secondary research from clinical and regulatory datasets, validated with direct interviews across dermatology, pharmacy, payer, and industry leadership. All findings and segmentation are verified via subject matter review, ensuring reliability for strategic business planning.

Why This Report Matters

Empowers executive teams to align development, market access, and operational planning for robust positioning in global atopic dermatitis therapies.
Delivers actionable insights for regional and channel optimization, guiding decisions on resource allocation and expansion opportunities.
Supports adaptation to evolving tariffs, payer demands, and scientific advancements, enabling informed and risk-mitigated strategies.

Conclusion

Advances in atopic dermatitis therapeutics, adaptive delivery solutions, and supply chain strategies are shaping the sector’s direction. Executives who integrate these evolving trends with operational resilience will secure stronger market positioning and sustained growth amid ongoing industry transformation.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Atopic Dermatitis Drugs Market, by Drug Class

8.1. Systemic
8.1.1. Biologics
8.1.2. Small Molecule Immunosuppressants
8.2. Topical
8.2.1. Calcineurin Inhibitors
8.2.2. Corticosteroids
8.2.3. PDE4 Inhibitors
8.2.4. Vitamin D Analogues

9. Atopic Dermatitis Drugs Market, by Route Of Administration

9.1. Cream
9.2. Gel
9.3. Lotion
9.4. Ointment

10. Atopic Dermatitis Drugs Market, by Mode Of Administration

10.1. Injectable
10.1.1. Pre Filled Syringes
10.1.2. Vials
10.2. Oral

11. Atopic Dermatitis Drugs Market, by Patient Age Group

11.1. Adult
11.2. Geriatric
11.3. Pediatric

12. Atopic Dermatitis Drugs Market, by Distribution Channel

12.1. Hospital Pharmacies
12.1.1. Private Hospital Pharmacies
12.1.2. Public Hospital Pharmacies
12.2. Online Pharmacies
12.2.1. Digital Health Platforms
12.2.2. E Commerce Platforms
12.3. Retail Pharmacies
12.3.1. Chain Pharmacies
12.3.2. Independent Pharmacies

13. Atopic Dermatitis Drugs Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Atopic Dermatitis Drugs Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Atopic Dermatitis Drugs Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Atopic Dermatitis Drugs Market
17. China Atopic Dermatitis Drugs Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Almirall, S.A.
18.7. Amgen Inc.
18.8. Arcutis Biotherapeutics, Inc.
18.9. Bausch Health Companies Inc.
18.10. BiomX Inc.
18.11. Bristol-Myers Squibb Company
18.12. Dermavant Sciences Inc.
18.13. Eli Lilly and Company
18.14. Galderma Group AG
18.15. Glenmark Pharmaceuticals Ltd.
18.16. Incyte Corporation
18.17. Intas Pharmaceuticals Ltd.
18.18. Kiniksa Pharmaceuticals, Ltd.
18.19. Kyowa Hakko Kirin Co., Ltd.
18.20. LEO Pharma A/S
18.21. Novartis AG
18.22. Otsuka Holdings Co., Ltd.
18.23. Pfizer Inc.
18.24. Regeneron Pharmaceuticals, Inc.
18.25. Sanofi S.A.
18.26. Sun Pharmaceutical Industries Ltd.
18.27. Teva Pharmaceutical Industries Ltd.
18.28. UCB S.A.
18.29. Vanda Pharmaceuticals, Inc.

List of Figures

FIGURE 1. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ATOPIC DERMATITIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SMALL MOLECULE IMMUNOSUPPRESSANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SMALL MOLECULE IMMUNOSUPPRESSANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SMALL MOLECULE IMMUNOSUPPRESSANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VITAMIN D ANALOGUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VITAMIN D ANALOGUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VITAMIN D ANALOGUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CREAM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY LOTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY LOTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY LOTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRE FILLED SYRINGES, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRE FILLED SYRINGES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRE FILLED SYRINGES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DIGITAL HEALTH PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DIGITAL HEALTH PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DIGITAL HEALTH PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 110. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 122. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 146. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 148. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 149. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 150. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 151. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 152. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 153. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 154. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 155. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 156. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 157. EUROPE ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 158. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 160. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 170. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 172. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 173. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 174. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 175. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 177. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 178. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 180. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 181. AFRICA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 195. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 196. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 197. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 198. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 199. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 200. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 202. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 203. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 204. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 205. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 206. ASEAN ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 207. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 209. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 210. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 211. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 212. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 214. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 215. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 217. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 218. GCC ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 219. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 221. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 231. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 233. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 234. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 235. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 238. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 239. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 240. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 241. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 242. BRICS ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 243. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 245. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 246. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 247. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 248. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 250. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 251. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 252. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 253. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 254. G7 ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 255. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 256. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 257. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 258. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 259. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 260. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 261. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 262. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 263. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 264. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 265. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 266. NATO ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 267. GLOBAL ATOPIC DERMATITIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 268. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 269. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 270. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 280. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 281. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 282. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY SYSTEMIC, 2018-2032 (USD MILLION)
TABLE 283. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY TOPICAL, 2018-2032 (USD MILLION)
TABLE 284. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 285. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 286. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2032 (USD MILLION)
TABLE 287. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
TABLE 288. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 289. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 290. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 291. CHINA ATOPIC DERMATITIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Atopic Dermatitis Drugs market report include:

AbbVie Inc.
Almirall, S.A.
Amgen Inc.
Arcutis Biotherapeutics, Inc.
Bausch Health Companies Inc.
BiomX Inc.
Bristol-Myers Squibb Company
Dermavant Sciences Inc.
Eli Lilly and Company
Galderma Group AG
Glenmark Pharmaceuticals Ltd.
Incyte Corporation
Intas Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals, Ltd.
Kyowa Hakkō Kirin Co., Ltd.
LEO Pharma A/S
Novartis AG
Otsuka Holdings Co., Ltd.
Pfizer Inc.
Regeneron Pharmaceuticals, Inc.
Sanofi S.A.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
UCB S.A.
Vanda Pharmaceuticals, Inc.

Table Information

Report Attribute	Details
No. of Pages	183
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 9.84 Billion
Forecasted Market Value ( USD ) by 2032	$ 15.78 Billion
Compound Annual Growth Rate	8.0%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3505EUR$3,939USD£3,044GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3781EUR$4,249USD£3,283GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5125EUR$5,759USD£4,450GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6201EUR$6,969USD£5,385GBP

Market Snapshot: Atopic Dermatitis Drugs Market

Scope & Segmentation

Key Takeaways: Evolving Landscape in Atopic Dermatitis Drugs

Tariff Impact on Supply Chains and Pricing

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Moderate To Severe Atopic Dermatitis - Pipeline Insight, 2025

Atopic Dermatitis Drugs - Global Strategic Business Report

Atopic Dermatitis Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

Atopic Dermatitis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Atopic Dermatitis - Pipeline Insight, 2025